UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Simultaneous pharmacokinetic modeling of unbound and total darunavir with ritonavir in adolescents: a substudy of the SMILE trial

Antimicrobial agents and chemotherapy, 2024-02, Vol.68 (2), p.e0100423-e0100423

2024

Volltextzugriff (PDF)

Population pharmacokinetics of unbound and total dolutegravir concentrations in children aged 12 years and older: a PK substudy of the SMILE trial

Journal of antimicrobial chemotherapy, 2023-04, Vol.78 (4), p.1041-1049

2023

Volltextzugriff (PDF)

Bayesian Parameter Estimates of Nelfinavir and Its Active Metabolite, Hydroxy-tert-Butylamide, in Infants Perinatally Infected with Human Immunodeficiency Virus Type 1

Antimicrobial Agents and Chemotherapy, 2005-02, Vol.49 (2), p.525-535

2005

Volltextzugriff (PDF)

Neurocognition and quality of life after reinitiating antiretroviral therapy in children randomized to planned treatment interruption

AIDS (London), 2016-04, Vol.30 (7), p.1075-1081

2016

Volltextzugriff (PDF)

HIV-1 Drug Resistance and Second-Line Treatment in Children Randomized to Switch at Low Versus Higher RNA Thresholds

Journal of acquired immune deficiency syndromes (1999), 2015-09, Vol.70 (1), p.42-53

2015

Volltextzugriff (PDF)

Outcomes after reinitiating antiretroviral therapy in children randomized to planned treatment interruptions

AIDS (London), 2013-02, Vol.27 (4), p.579-589

2013

Volltextzugriff (PDF)

PENTA 2009 guidelines for the use of antiretroviral therapy in paediatric HIV‐1 infection

HIV medicine, 2009-11, Vol.10 (10), p.591-613

2009

Volltextzugriff (PDF)

Hepatic, Renal, Hematologic, and Inflammatory Markers in HIV-Infected Children on Long-term Suppressive Antiretroviral Therapy

Journal of the Pediatric Infectious Diseases Society, 2017-09, Vol.6 (3), p.e109-e115

2017

Volltextzugriff (PDF)

Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents, and young adults (BREATHER): a randomised, open-label, non-inferiority, phase 2/3 trial

The lancet HIV, 2016-09, Vol.3 (9), p.e421-e430

2016

Volltextzugriff (PDF)

Population analysis of the pregnancy-related modifications in lopinavir pharmacokinetics and their possible consequences for dose adjustment

Journal of antimicrobial chemotherapy, 2009-06, Vol.63 (6), p.1223-1232

2009

Volltextzugriff (PDF)

Pharmacokinetics of pediatric lopinavir/ritonavir tablets in children when administered twice daily according to FDA weight bands

The Pediatric infectious disease journal, 2014-03, Vol.33 (3), p.301-305

2014

Volltextzugriff (PDF)

Pharmacokinetic study of once-daily versus twice-daily abacavir and lamivudine in HIV type-1-infected children aged 3-<36 months

Antiviral therapy, 2010-01, Vol.15 (3), p.297-305

2010

Volltextzugriff (PDF)

Pregnancy outcomes in women with HIV type―1 receiving a lopinavir/ritonavir―containing regimen

Antiviral therapy, 2009-01, Vol.14 (3), p.423-432

2009

Volltextzugriff (PDF)

Adherence to Antiretroviral Therapy and Acceptability of Planned Treatment Interruptions in HIV-Infected Children

AIDS and behavior, 2013-01, Vol.17 (1), p.193-202

2013

Volltextzugriff (PDF)

Persistence of multidrug-resistant HIV-1 without antiretroviral treatment 2 years after sexual transmission

Antiviral therapy, 2004-06, Vol.9 (3), p.415-421

2004

Volltextzugriff (PDF)

Plasma Drug Concentrations and Virologic Evaluations after Stopping Treatment with Nonnudeoside Reverse-Transcriptase Inhibitors in HIV Type 1-Infected Children

Clinical infectious diseases, 2008-05, Vol.46 (10), p.1601-1608

2008

Volltextzugriff (PDF)

Pharmacokinetics of nelfinavir and its active metabolite, hydroxy-tert-butylamide, in infants perinatally infected with human immunodeficiency virus type 1

The Pediatric infectious disease journal, 2003-01, Vol.22 (1), p.48-55

2003

Volltextzugriff (PDF)

Evolution of antiretroviral phenotypic and genotypic drug resistance in antiretroviral-naive HIV-1-infected children treated with abacavir/lamivudine, zidovudine/lamivudine or abacavir/zidovudine, with or without nelfinavir (the PENTA 5 trial)

Antiviral therapy, 2002-12, Vol.7 (4), p.293-303

2002

Volltextzugriff (PDF)

A randomized controlled trial of genotypic HIV drug resistance testing in HIV-1-infected children : the PERA (PENTA 8) Trial

Antiviral therapy, 2006-01, Vol.11 (7), p.857-867

2006

Volltextzugriff (PDF)

Dénutrition et infections bronchopulmonaires

Nutrition clinique et métabolisme, 1994, Vol.8 (1), p.45-50

1994

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(29)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(26)
Humans
(25)
Life Sciences & Biomedicine
(25)
Infectious Diseases
(19)
Hiv Infections - Drug Therapy
(18)
Child
(17)
Female
(17)
Adolescent
(15)
Male
(15)
Hiv
(13)
Biological And Medical Sciences
(12)
Medical Sciences
(12)
Children
(11)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(10)
Child, Preschool
(10)
Pharmacology. Drug Treatments
(10)
Antiviral Agents
(9)
Infant
(9)
Pharmacology & Pharmacy
(9)
Adult
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents and young adults (BREATHER): Extended follow-up results of a randomised, open-label, non-inferiority trial

Early antiretroviral therapy in children perinatally infected with HIV: a unique opportunity to implement immunotherapeutic approaches to prolong viral remission

Simultaneous pharmacokinetic modeling of unbound and total darunavir with ritonavir in adolescents: a substudy of the SMILE trial

Population pharmacokinetics of unbound and total dolutegravir concentrations in children aged 12 years and older: a PK substudy of the SMILE trial

Follow-up for 3 years of a pediatric population diagnosed in 2018 with mother-to-child transmission of HIV in 8 Latin American countries in the PLANTAIDS cohort

Bayesian Parameter Estimates of Nelfinavir and Its Active Metabolite, Hydroxy-tert-Butylamide, in Infants Perinatally Infected with Human Immunodeficiency Virus Type 1

Neurocognition and quality of life after reinitiating antiretroviral therapy in children randomized to planned treatment interruption

HIV-1 Drug Resistance and Second-Line Treatment in Children Randomized to Switch at Low Versus Higher RNA Thresholds

Outcomes after reinitiating antiretroviral therapy in children randomized to planned treatment interruptions

PENTA 2009 guidelines for the use of antiretroviral therapy in paediatric HIV‐1 infection

Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents and young adults

Hepatic, Renal, Hematologic, and Inflammatory Markers in HIV-Infected Children on Long-term Suppressive Antiretroviral Therapy

Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents, and young adults (BREATHER): a randomised, open-label, non-inferiority, phase 2/3 trial

Paediatric European Network for Treatment of AIDS Treatment Guideline 2016 update: antiretroviral therapy recommended for all children living with HIV

Population analysis of the pregnancy-related modifications in lopinavir pharmacokinetics and their possible consequences for dose adjustment

Pharmacokinetics of pediatric lopinavir/ritonavir tablets in children when administered twice daily according to FDA weight bands

Pharmacokinetic study of once-daily versus twice-daily abacavir and lamivudine in HIV type-1-infected children aged 3-<36 months

Pregnancy outcomes in women with HIV type―1 receiving a lopinavir/ritonavir―containing regimen

Adherence to Antiretroviral Therapy and Acceptability of Planned Treatment Interruptions in HIV-Infected Children

Persistence of multidrug-resistant HIV-1 without antiretroviral treatment 2 years after sexual transmission

Plasma Drug Concentrations and Virologic Evaluations after Stopping Treatment with Nonnudeoside Reverse-Transcriptase Inhibitors in HIV Type 1-Infected Children

Pharmacokinetics of nelfinavir and its active metabolite, hydroxy-tert-butylamide, in infants perinatally infected with human immunodeficiency virus type 1

Evolution of antiretroviral phenotypic and genotypic drug resistance in antiretroviral-naive HIV-1-infected children treated with abacavir/lamivudine, zidovudine/lamivudine or abacavir/zidovudine, with or without nelfinavir (the PENTA 5 trial)

A randomized controlled trial of genotypic HIV drug resistance testing in HIV-1-infected children : the PERA (PENTA 8) Trial

Dénutrition et infections bronchopulmonaires

Suchergebnisse filtern